Brain lesions and cognitive decline in patients with atrial fibrillation: a prospective multicentre cohort study.

IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Katalin Bhend, Rebecca Paladini, Stefanie Aeschbacher, Elisa Hennings, Michael Coslovsky, Philipp Krisai, Nicolas Rodondi, Jürg Beer, Angelo Auricchio, Giorgio Moschovitis, Nino Storrer, Patricia O Chocano-Bedoya, Elia Rigamonti, Tim Sinnecker, David Conen, Stefan Osswald, Leo Bonati, Michael Kühne
{"title":"Brain lesions and cognitive decline in patients with atrial fibrillation: a prospective multicentre cohort study.","authors":"Katalin Bhend, Rebecca Paladini, Stefanie Aeschbacher, Elisa Hennings, Michael Coslovsky, Philipp Krisai, Nicolas Rodondi, Jürg Beer, Angelo Auricchio, Giorgio Moschovitis, Nino Storrer, Patricia O Chocano-Bedoya, Elia Rigamonti, Tim Sinnecker, David Conen, Stefan Osswald, Leo Bonati, Michael Kühne","doi":"10.57187/s.4059","DOIUrl":null,"url":null,"abstract":"<p><strong>Study aim: </strong>Atrial fibrillation (AF) is associated with a high burden of vascular brain lesions, most of which are covert. We aimed to assess the association between vascular brain lesions (brain infarcts, microbleeds, white matter lesions) and cognitive decline over time in atrial fibrillation patients.</p><p><strong>Methods: </strong>We included 1536 atrial fibrillation patients with brain magnetic resonance imaging (MRI) from a prospective multicentre cohort study. Patients were enrolled between 2014 and 2017 across 14 centres in Switzerland. Their cognitive functioning was assessed at baseline and yearly intervals using Montreal Cognitive Assessment (MoCA) and Cognitive Construct (CoCo) scores. Cognitive decline was defined as a score decline of >1 standard deviation of the age- and education-standardised baseline population compared with individual baseline levels of the corresponding test.</p><p><strong>Results: </strong>Of 1536 patients, 1030 (mean age: 72 years; 73% male) had ≥1 vascular brain lesion on baseline MRI. During a median follow-up of 5.13 years, cognitive decline developed in 159 (10%) patients based on MoCA scores and in 144 (9%) based on CoCo scores. The incidence rate (per 100 person-years) for cognitive decline was 3.64 in patients with brain lesions vs 1.82 in patients without brain lesions on baseline MRI using MoCA scores, and 3.18 vs 2.0 using CoCo scores. In multivariable adjusted Cox proportional hazard models, the hazard ratio (HR) (95% confidence interval [CI]) of any brain lesion for cognitive decline was 1.29 (0.85-1.96) using the MoCA and 1.45 (0.95-2.20) using the CoCo score.</p><p><strong>Conclusions: </strong>In our atrial fibrillation cohort, the presence of brain lesions was not associated with a higher risk of cognitive decline using the MoCA or the CoCo score. However, there was an association with more-specific cognitive domains.</p><p><strong>Trial registration: </strong>https://clinicaltrials.gov NCT02105844.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"156 ","pages":"4059"},"PeriodicalIF":1.6000,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss medical weekly","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.57187/s.4059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Study aim: Atrial fibrillation (AF) is associated with a high burden of vascular brain lesions, most of which are covert. We aimed to assess the association between vascular brain lesions (brain infarcts, microbleeds, white matter lesions) and cognitive decline over time in atrial fibrillation patients.

Methods: We included 1536 atrial fibrillation patients with brain magnetic resonance imaging (MRI) from a prospective multicentre cohort study. Patients were enrolled between 2014 and 2017 across 14 centres in Switzerland. Their cognitive functioning was assessed at baseline and yearly intervals using Montreal Cognitive Assessment (MoCA) and Cognitive Construct (CoCo) scores. Cognitive decline was defined as a score decline of >1 standard deviation of the age- and education-standardised baseline population compared with individual baseline levels of the corresponding test.

Results: Of 1536 patients, 1030 (mean age: 72 years; 73% male) had ≥1 vascular brain lesion on baseline MRI. During a median follow-up of 5.13 years, cognitive decline developed in 159 (10%) patients based on MoCA scores and in 144 (9%) based on CoCo scores. The incidence rate (per 100 person-years) for cognitive decline was 3.64 in patients with brain lesions vs 1.82 in patients without brain lesions on baseline MRI using MoCA scores, and 3.18 vs 2.0 using CoCo scores. In multivariable adjusted Cox proportional hazard models, the hazard ratio (HR) (95% confidence interval [CI]) of any brain lesion for cognitive decline was 1.29 (0.85-1.96) using the MoCA and 1.45 (0.95-2.20) using the CoCo score.

Conclusions: In our atrial fibrillation cohort, the presence of brain lesions was not associated with a higher risk of cognitive decline using the MoCA or the CoCo score. However, there was an association with more-specific cognitive domains.

Trial registration: https://clinicaltrials.gov NCT02105844.

心房颤动患者的脑损伤和认知能力下降:一项前瞻性多中心队列研究。
研究目的:心房颤动(AF)与血管性脑病变的高负担有关,其中大多数是隐蔽的。我们旨在评估心房颤动患者血管性脑病变(脑梗死、微出血、白质病变)与认知能力下降之间的关系。方法:我们从一项前瞻性多中心队列研究中纳入1536例房颤患者的脑磁共振成像(MRI)。患者于2014年至2017年在瑞士的14个中心登记入组。使用蒙特利尔认知评估(MoCA)和认知结构(CoCo)评分对他们的认知功能进行基线和年度间隔评估。认知能力下降定义为与相应测试的个体基线水平相比,年龄和教育标准化基线人群的得分下降bb0.1个标准差。结果:1536例患者中,1030例(平均年龄72岁,73%为男性)在基线MRI上有≥1个脑血管性病变。在中位5.13年的随访期间,159名(10%)MoCA评分患者和144名(9%)CoCo评分患者出现认知能力下降。使用MoCA评分的基线MRI显示,脑病变患者认知能力下降的发生率(每100人年)为3.64比1.82,使用CoCo评分的基线MRI为3.18比2.0。在多变量校正Cox比例风险模型中,任何脑损伤对认知能力下降的风险比(HR)(95%可信区间[CI])使用MoCA评分为1.29(0.85-1.96),使用CoCo评分为1.45(0.95-2.20)。结论:在我们的房颤队列中,使用MoCA或CoCo评分,脑病变的存在与认知能力下降的高风险无关。然而,这与更具体的认知领域有关。试验注册:https://clinicaltrials.gov NCT02105844。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Swiss medical weekly
Swiss medical weekly 医学-医学:内科
CiteScore
5.00
自引率
0.00%
发文量
0
审稿时长
3-8 weeks
期刊介绍: The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书